As the nation is gripped with the opioid epidemic, CHIME has launched a new task force to address this epidemic that has caused over 42,000 opioid related drug overdoses in 2016. As an organization representing and bringing together our nation’s healthcare information technology leaders, we are in a position to make an immense impact on our fellow Americans’ lives by using technology to bend the curve of opioid addiction. As we continue to move forward with our new initiative, we look to work with both public entities and private organizations to end this crisis.
CHIME Top Recommendations to Policymakers
- Leverage the use of technology, existing infrastructure and data to better inform care delivery in treating patients with opioid addiction.
Letters to the Administration
- X-Waiver Sign-On Letter to Congressional Leadership (July 2021)
- CHIME Letter to Secretary Becerra on X-Waiver (April 2021)
- CHIME Response to CMS Electronic Prescribing of Controlled Substances; Request for Information (RFI) (Oct. 2020)
- CHIME letter to SAMHSA on Part 2 (Oct. 2019)
- CHIME Submits MIPS Improvement Activity Ideas around Opioids (Mar 2018)
- CHIME comments to Federal Communications Commission regarding The Rural Health Care Program (Feb 2018)
Congressional Letters & Testimony
- Sign on Letter to Congressional Leaders re: The Mainstreaming Addiction Treatment Act (H.R. 1384 / S. 445) (May 2021)
- CHIME letter of Support to Senators Manchin and Capito on Jessie’s Law (Mar 2020)
- CHIME Letter of Support for the Protecting Jessica Grubb’s Legacy Act (S. 1012) (April 2019)
- CHIME Letter of Support for the Overdose Prevention and Patient Safety (OPPS) Act (H.R. 2062) (April 2019)
- CHIME Letter to Congressional Leadership on Final Opioids Package (Sep 2018)
- CHIME signs onto second multi-stakeholder letter in support of amending 42 CFR Part 2 (Sep 2018)
- CHIME signs onto multi-stakeholder letter in support of amending 42 CFR Part 2 (Jun 2018)
- CHIME signs onto multi-stakeholder letter support electronic prescribing of controlled substances bill (Apr 2018)
- CHIME submits letter of support for HR 3545 – “Overdose Prevention and Patient Safety Act” (Apr 2018)
- CHIME submits statement to Senate HELP on opioids (Apr 2018)
- CHIME submits statement for the record to Energy & Commerce Health Subcommittee on opioids (Apr 2018)
- CHIME submits comments to House Committee on Ways & Means (Mar 2018)
- CHIME comments to The Senate Finance Committee’s request for policy recommendations around opioid use disorder (OUD) (Feb 2018)
- CHIME statement for the record: Senate Health, Education, Labor & Pensions Committee hearing on “The Opioid Crisis: The Role of Technology and Data in Preventing and Treating Addiction “ (Feb 2018)